Fundraising Fox

Lyora Therapeutics

Belmont, US · Founded 2024 · Delaware corporation

Biotech

Founders & leadership

LV
Luc Vandenberghe, PhDNamed on SEC filing

Board

EP
Eric Pierce, MD, PhDBoard director

Funding

SEC filings, press & company announcements

$525K disclosed across 1 of 2 rounds · 2025–2026

  • Undisclosed amountSeedJul 2026 · 3 sources
    Source ↗
▶$525KraisedMar 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luc Vandenberghe, PhDExecutive Officer, Director
  • Eric Pierce, MD, PhDDirector
Offering amount
$2M
Amount sold
$525K
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Five Questions With: Pam Stetkiewiczpbn.com · Aug 2026Velocity Currents - 19th Editionvelocitycurrents.beehiiv.com · Aug 2026Lyora Therapeutics Launches With Seed Funding to Advance Genetic Eye Disease Therapies | citybizcitybiz.co · Jul 2026Genetic medicine startup Lyora launches with programs from Editas, Biogenendpoints.news · Jul 2026Lyora Therapeutics Launches With $2.5M Seed Fundingallsci.com · Jul 2026Lyora Therapeutics Launches With Seed Funding to Propel Its Biologically Validated Pipeline of Genetic Medicines to Treat Inherited Retinal Diseasesglobenewswire.com · Jul 2026

Frequently asked questions

How much funding has Lyora Therapeutics raised?
Lyora Therapeutics has disclosed $525K raised across 1 of its 2 known rounds.
Where is Lyora Therapeutics headquartered?
Lyora Therapeutics is headquartered in Belmont, US.